Selumetinib-based therapy in uveal melanoma patient-derived xenografts

The prognosis of metastatic uveal melanoma (UM) is among the worst of all human cancers. The identification of near-ubiquitous GNAQ/GNA11 mutations and the activation of MAPK signaling in UM have raised hopes of more effective, targeted therapies, based on MEK inhibition, for example. We evaluated t...

Descripción completa

Detalles Bibliográficos
Autores principales: Decaudin, Didier, El Botty, Rania, Diallo, Béré, Massonnet, Gerald, Fleury, Justine, Naguez, Adnan, Raymondie, Chloé, Davies, Emma, Smith, Aaron, Wilson, Joanne, Howes, Colin, Smith, Paul D., Cassoux, Nathalie, Piperno-Neumann, Sophie, Roman-Roman, Sergio, Némati, Fariba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955168/
https://www.ncbi.nlm.nih.gov/pubmed/29774094
http://dx.doi.org/10.18632/oncotarget.24670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955168/
https://www.ncbi.nlm.nih.gov/pubmed/29774094
http://dx.doi.org/10.18632/oncotarget.24670

Ejemplares similares